Sunflower Pharmaceutical Group Co.,Ltd (SHE:002737)
China flag China · Delayed Price · Currency is CNY
13.09
-0.12 (-0.91%)
May 20, 2026, 12:54 PM CST

SHE:002737 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,471852.821,0402,2872,3991,320
Short-Term Investments
-----304.42
Trading Asset Securities
1,2031,7551,2581,3151,449668.69
Cash & Short-Term Investments
2,6742,6082,2983,6023,8472,293
Cash Growth
11.40%13.47%-36.19%-6.38%67.77%27.52%
Accounts Receivable
131.82182.31584.93110.13184.25268.98
Other Receivables
10.578.8214.9541.4242.5712.21
Receivables
142.39191.13599.88151.56226.82281.19
Inventory
654.05617.43867.31873.19632.08709.64
Prepaid Expenses
-11.5431.6844.33.748.75
Other Current Assets
91.873.6188.23116.81151.03100.11
Total Current Assets
3,5623,5023,8864,7884,8613,393
Property, Plant & Equipment
1,1871,2081,3111,4351,4971,577
Long-Term Investments
7894.8897.12122.44141.38131.32
Goodwill
56.4456.4486.9891.7791.77107.6
Other Intangible Assets
307.95312.73332.64345.37366.52337.77
Long-Term Deferred Tax Assets
65.7864.1537.6258.9256.5155.78
Long-Term Deferred Charges
5.656.7510.038.866.811.87
Other Long-Term Assets
92.4383.964.8931.3910.8530.77
Total Assets
5,3565,3285,8266,8827,0325,635
Accounts Payable
411.75421.62319.05734.6714.48547.18
Accrued Expenses
74.13136.84205.55233.76301.01124.75
Short-Term Debt
105108.490.0214.43420200
Current Portion of Leases
-4.444.954.465.593.5
Current Income Taxes Payable
41.085.964.7387.5360.2143.54
Current Unearned Revenue
230.61272.57285.68297.32551.54167.04
Other Current Liabilities
201.45201.6207.55147.8122.54166.6
Total Current Liabilities
1,0681,1521,0281,5202,1751,253
Long-Term Debt
-----33.57
Long-Term Leases
1.5934.037.6210.57.01
Long-Term Unearned Revenue
175.26178.83199.37342.08397.26389.08
Long-Term Deferred Tax Liabilities
2.593.014.957.619.8917.82
Other Long-Term Liabilities
1.31.3----
Total Liabilities
1,2491,3381,2361,8772,5931,700
Common Stock
584584584584584584
Additional Paid-In Capital
929.06929.06918.43915.66889.99896.7
Retained Earnings
2,4292,3182,8683,2522,7162,256
Treasury Stock
------44
Comprehensive Income & Other
6.926.99.1612.2814.3816.77
Total Common Equity
3,9493,8384,3794,7634,2053,709
Minority Interest
157.87152.37210.86241.25234225.72
Shareholders' Equity
4,1063,9914,5905,0054,4393,935
Total Liabilities & Equity
5,3565,3285,8266,8827,0325,635
Total Debt
111115.938.9926.52436.08244.08
Net Cash (Debt)
2,5632,4922,2893,5763,4112,049
Net Cash Growth
7.12%8.85%-35.97%4.82%66.47%37.72%
Net Cash Per Share
4.41-3.916.135.823.52
Filing Date Shares Outstanding
580.45-584584584587.54
Total Common Shares Outstanding
580.45-584584584587.54
Working Capital
2,4932,3502,8583,2682,6862,140
Book Value Per Share
6.80-7.508.167.206.31
Tangible Book Value
3,5843,4693,9604,3263,7463,264
Tangible Book Value Per Share
6.17-6.787.416.425.56
Buildings
-1,5651,5671,6121,6041,589
Machinery
-1,1451,1211,0751,014982.56
Construction In Progress
-32.3630.8435.730.2919.15
Source: S&P Global Market Intelligence. Standard template. Financial Sources.